ZTS
38
9
BIIB
45
3
ABT
50
3
NEE
54
-3
NTAP
65
4
ROST
52
2
PPG
64
3
ADP
58
-4
HST
49
-3
LLY
56
2
TXN
40
4
DFS
64
2
MSI
55
-3
ALL
51
7
TROW
58
10
CL
64
3
DRI
48
-12
AVB
62
-2
TSCO
66
11
NEM
61
-2
ZTS
38
9
BIIB
45
3
ABT
50
3
NEE
54
-3
NTAP
65
4
ROST
52
2
PPG
64
3
ADP
58
-4
HST
49
-3
LLY
56
2
TXN
40
4
DFS
64
2
MSI
55
-3
ALL
51
7
TROW
58
10
CL
64
3
DRI
48
-12
AVB
62
-2
TSCO
66
11
NEM
61
-2
Financhill
Back

BeyondSpring 10K Form

Sell
34

BYSI
BeyondSpring

Last Price:
2.11
Seasonality Move:
7.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BYSI News And Ratings

See the #1 stock for the next 7 days that we like better than BYSI

BYSI Financial Statistics

Sales & Book Value

Annual Sales: $1.35M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.46
Price / Book: 0

Profitability

EPS (TTM): -0.71000
Net Income (TTM): $-27.51M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

BeyondSpring Earnings Forecast

Key BeyondSpring Financial Ratios

  • The Research & Development expenses have been 1,893.56% of Revenue.
  • The Interest Expense is -0.05% of Operating Income.
  • The Net Earning history of BYSI is -2,463.29% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

BeyondSpring Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BYSI
CUSIP: G10830
Website: beyondspringpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BYSI Technical Analysis vs Fundamental Analysis

Sell
34
BeyondSpring (BYSI) is a Sell

Is BeyondSpring a Buy or a Sell?

  • BeyondSpring stock is rated a Sell
    The current BeyondSpring [BYSI] share price is $2.13. The Score for BYSI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.